| SEPTEMBER
11, 2004 SATURDAY |
| 09.00-18.00 |
Patent Workshop |
| SEPTEMBER
12, 2004 SUNDAY |
| 09.00-18.00 |
Validation Workshop |
| 17.00-20.00 |
Registration |
| 20.00-22.00 |
Welcome Cocktail |
| SEPTEMBER
13, 2004 MONDAY |
| 8.00-9.00 |
Registration |
| 9.00-10.15 |
Opening Ceremony |
| Chairs |
A. A. Hıncal (TR), M. Şumnu (TR), N. Ünlü (TR) |
| 10.15-11.00 |
Coffee Break |
Morning
Session: 11.00-12.30
Opening Invited Lectures |
| Chairs |
D. K. F. Meijer (NL), A. A. Hıncal (TR)
|
| 11.00-11.30 |
Drug Delivery and Absorption
of Peptides and Proteins (Vaccines)
H. E. Junginger
LACDR, Gorlaeus Laboratories-The Netherlands
|
| 11.30-11.40 |
Discussion |
| 11.40-12.10 |
Drug Delivery Systems
to the Brain
Y. Sugiyama
The University of Tokyo-Japan
|
| 12.10-12.20 |
Discussion |
| 12.20-12.30 |
Group Photo |
| 12.30-13.30 |
Lunch |
| 13.30-14.30 |
Poster Session |
Afternoon
-1st Session: 14.30-16.00
Peptide-Protein Delivery
|
| Chairs |
A. Urtti (FI), Y. Çapan (TR) |
| 14.30-14.55 |
Artificial Viruses
– The Role of Membrane-Active Peptides in Intracellular Delivery
E. Wagner
University of Muenchen-Germany
|
| 14.55-15.00 |
Discussion |
| 15.00-15.25 |
New Oral Formulations
of Heparin
N. Ubrich
University of Nancy I-France
|
| 15.25-15.30 |
Discussion |
| 15.30-15.55 |
Development of Novel
Delivery System of Site Specific PEGylated Peptide Drugs
K. C. Lee
Sung Kyun Kwan University-Republic of Korea
|
| 15.55-16.00 |
Discussion |
| 16.00-16.20 |
Coffee Break |
Afternoon-2nd
Session:16.20-17.50
Gene and Vaccine Delivery/Targeting |
| Chairs |
D. Duchêne (F), M. Şumnu (TR) |
| 16.20-16.45 |
Dual Drug Targeting
Using Therapeutic Proteins as Carriers for Cell Selective Delivery
D. K. F. Meijer
Groningen University-The Netherlands
|
| 16.45-16.50 |
Discussion |
| 16.50-17.15 |
Nanoscale Vaccine Carriers
M. J. Alonso
University of Santiago de Compostela-Spain
|
| 17.15-17.20 |
Discussion |
| 17.20-17.45 |
Gene Delivery
I. Uchegbu
University of Strathclyde-United Kingdom |
| 17.45-17.50 |
Discussion |
| 17.50-18.15 |
Non-invasive vaccines:
New strategies for vaccine development
O. Alpar
University of London-United Kingdom |
| 18.15-18.20 |
Discussion |
| SEPTEMBER
14, 2004 TUESDAY |
Morning-1st
Session: 9.00-10.50
Other Routes |
| Chairs |
E. Wagner (DE), S. Şenel (TR) |
| 9.00-9.25 |
Nanotechnology - Characterization
of Implantable Drug Delivery Systems
A. Goepferich
University Regensburg-Germany |
| 9.25-9.30 |
Discussion |
| 9.30-9.55 |
Epidermal Cell Culture
Model for Transdermal Drug Delivery Studies
A. Urtti
University of Kuopio-Finland |
| 9.55-10.00 |
Discussion |
| 10.00-10.25 |
Modified Release Veterinary
Drug Delivery – Challenges and Solutions
M. J. Rathbone
InterAg-New Zealand |
| 10.25-10.30 |
Discussion |
| 10.30-10.50 |
Coffee Break |
Morning-2nd
Session: 10.50-12.20
New Approaches to Medical Protection and Formulation Development Against
Chemical Warfare |
| Chairs |
D. H. Moore (USA), F. Hıncal (TR) |
| 10.50-11.15 |
From Laboratory to
Clinical Trial: Regulatory Compliance During Product Development
D. Robinson
Battelle-United States of America |
| 11.15-11.20 |
Discussion |
| 11.20-11.45 |
Medical and Pharmaceutical
Countermeasures to Chemical Warfare Agents
D. H. Moore
Battelle-United States of America |
| 11.45-11.50 |
Discussion |
| 11.50-12.15 |
Pharmaceutical Implications
of New Iodine Formulations
U. Wormser
Hebrew University-Israel |
| 12.15-12.20 |
Discussion |
| 12.20-13.30 |
Lunch |
| 13.30-17.00 |
Poster Session |
| 20.00-24.00 |
Closing Dinner |
| SEPTEMBER
15, 2004 WEDNESDAY |
Morning-1st
Session: 9.00-10.50
Drug Delivery/Drug Development (I) |
| Chairs |
H. Junginger (NL), S. Çalış (TR)
| "
| 9.00-9.25 |
Human Absorption and
Microdosing Studies to Innovate the Drug Development Process
I. Wilding
Pharmaceutical Profiles Ltd-United Kingdom |
| 9.25-9.30 |
Discussion |
| 9.30-9.55 |
Pharmacokinetic and
Gammascintigraphic Studies with Site Specific Oral Formulations
P. Veski & M. Marvola
University of Tartu-Estonia |
| 9.55-10.00 |
Discussion |
| 10.00-10.25 |
Improving Pulmonary
Drug Delivery by Particle Design
H. Steckel
Christian Albrechts Universitat zu Kiel-Germany |
| 10.25-10.30 |
Discussion |
| 10.30-10.50 |
Coffee Break |
Morning-2nd
Session: 10.50-12.20
Drug Delivery/Drug Development (II) |
| Chairs |
A. P. Sam (NL), N. Ünlü (TR)
|
| 10.50-11.15 |
Novel Non Aqueous Formulations:
Emulsions and Ionic Liquids
A. T. Florence
University of London-United Kingdom |
| 11.10-11.20 |
Discussion |
| 11.20-11.45 |
In vitro-In vivo Correlation
as Guide in Modified Release Drug Development
W. Martin
Pharmakin GmbH-Germany |
| 11.45-11.50 |
Discussion |
| 11.50-12.15 |
Risk Assessment in
Drug Development
A. P. Sam
NV Organon-The Netherlands |
| 12.15-12.20 |
Discussion |
| 12.20-13.30 |
Lunch |
| 13.30-14.30 |
Poster Session |
Afternoon
Session: 14.30-17.00
ROUND TABLE |
| Subject |
Discussion on The Symposium
Topic |
| Moderator |
A. T. Florence
University of London-United Kingdom |
| 17.00-18.00 |
Closing Remarks |
| Ceremony |
- Best Poster Award
- Best M.Sc. and Ph.D. Thesis Award
- IPTS/Pfizer-Alev Sonat Research
Award on Intellectual Property
Rights in the Pharmaceutical Industry |
